アルキルイソシアナートは,キモトリプシンとエラスタゼの活性サイト特異的阻害剤として作用する
Science (New York, N.Y.)
|November 5, 1971
まとめ
アルキルイソシアネートは,キモトリプシンやエラスタゼのようなセリンタンパク質酵素を選択的に不活性化する. オクチルおよびブチルイソシアネートなどの異なるアルキル鎖の長さは,これらの酵素の異なる活性部位の大きさを明らかにします.
科学分野:
- バイオケミストリー バイオケミストリー
- 酵素学 酵素学とは
- 化学生物学 化学生物学とは
背景:
- キモトリプシンとエラスタゼは,構造が似ているセリンタンパク質ゼです.
- 酵素の活性部位の次元を理解することは,薬剤設計とメカニズム研究において極めて重要です.
研究 の 目的:
- アルキルイソシアネートとキモトリプシンとエラスタゼの反応性の違いを調査する.
- 酵素活性部位の特徴化のための化学探査機としてアルキルイソシアネートの可能性を調査する.
主な方法:
- チモトリプシンとエラスタゼの活性を測定するために,酵素測定が行われました.
- 様々なアルキルイソシアネート (オクチル,ブチルイソシアネートなど) を用いて反応運動を研究した.
- 酵素への反応剤の組み込みの量化が決定されました.
主要な成果:
- アルキルイソシアネートは,キモトリプシンとエラスタゼの両方を特異的に不活性化し,1:1の酵素-反応剤添加物を形成します.
- オクチルイソシアネートは選択的に不活性化したキモトリプシンである.
- ブチルイソシアネートは両方の酵素を不活性化させ,弾性酵素に対する効率が高くなった.
結論:
- アルキルイソシアネートは,酵素活性部位の相対的な大きさを調べるための貴重な化学"ヤードスティック"として機能します.
- 異なる不活性化パターンは,キモトリプシンとエラスタゼの活性部位の間の微妙な構造的違いを強調しています.
- この研究は,特定の化学反応剤との反応性に基づいて,密接に関連したセリンプロテアスを区別するための方法を提供します.
関連する概念動画
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
02:34Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
01:13Introduction to Mechanisms of Enzyme Catalysis
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes a mild...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...